Use of N- ( dibenz (b, f) oxepin10-ylmethyl ) N-methyl-Nprop2 - ynylamine (omigapil) for the prophylaxis and / or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency
Details for Australian Patent Application No. 2007236161 (hide)
International Classifications
Event Publications
9 October 2008 PCT application entered the National Phase
PCT publication WO2007/115776 Priority application(s): WO2007/115776
10 December 2009 Application Accepted
Published as AU-B-2007236161
8 April 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser